Skip to content

Public FDA record

Z-0419-2019: OviTex Reinforced BioScaffold 16x20cm, Part Number F10254-1620G

Recall record Z-0419-2019 for AROA Biosurgery, LTD.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0419-2019
Company in FDA record
AROA Biosurgery, LTD.
FDA record creation date
Nov 9, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Source facts

Action
Beginning in April 2018, customers were visited by representatives and the affected units were replaced.
Initiated
2018-04-06
Root cause
Other
Terminated
2019-04-15
Distribution
The products were distributed to the following US states: AL, CA, FL, IN, MA, MI, NH, and NY.
Recall number
Z-0419-2019
Recall status
Terminated
CDRH record ID
167626
FDA record created
2018-11-09
Recall event number
81166

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗